11/08/2012 - 10:42am

The Food and Drug Administration has accepted an application from Merck for an experimental drug for insomnia, the drug maker said Thursday.

11/07/2012 - 3:38pm

The National Community Pharmacists Association on Wednesday commended seven U.S. Representatives for recently writing the U.S. Centers for Medicare & Medicaid Services to urge the agency to allow independent community pharmacists to continue same-day home delivery of diabetes test supplies to certain Medicare beneficiaries.

11/07/2012 - 2:31pm

Americans woke up Wednesday morning to the news that Barack Obama had won a second term as president of the United States. DSN examines what it means for retail pharmacy.

11/07/2012 - 11:07am

A recent University of Cincinnati study suggested adolescent males are at a higher risk of reporting longtime abuse of over-the-counter drugs, compared with their female peers.

11/07/2012 - 10:59am

Liquor can cost $2 more at liquor stores in states where the government has a monopoly on sales than at privately owned stores, according to a new study.

11/07/2012 - 10:50am

The Food and Drug Administration on Monday issued a warning letter to The Avalon Effect, a company based in Franklin, Tenn., for its marketing of a light therapy product that claims to cure or treat symptoms of fungal meningitis, methicillin-resistant Staphylococcus aureus, concussions, Lyme disease and other diseases.

11/06/2012 - 4:08pm

The Food and Drug Administration has approved a drug for rheumatoid arthritis ahead of the day the agency was scheduled to decide whether or not to approve it, the agency said Tuesday.

11/06/2012 - 11:46am

Nutramax Laboratories recently announced the defeat of a class action lawsuit brought against the company in a California court. In April, Nutramax was named in a class action regarding its CosaminDS Joint Health Supplement. Plaintiffs claimed the glucosamine/chondroitin supplement did not work in relieving joint pain as advertised.

11/06/2012 - 11:23am

Pennsylvania Gov. Tom Corbett last week signed into law S.B. 201, a bill that takes critical steps toward leveling the playing field between large pharmacy benefit managers and the mail-order pharmacies they own and local, independent community pharmacies.